ArticleBMC medical informatics and decision making2026
Clinical subphenotypes in septic patients with new-onset atrial fibrillation: validation and parsimonious classifier model development.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe substantial heterogeneity among septic patients with new‑onset atrial fibrillation (NOAF) complicates intensive care unit (ICU) management, and the absence of a parsimonious subphenotype classifier has impeded the implementation of personalized therapeutic strategies. In this study, we aim to identify the subphenotype of septic patients with NOAF, develop a concise classifier model, and reveal the differential efficacy of heart-rate control therapies across these subphenotypes.
methodsThis retrospective study utilized data from the Medical Information Mart in Intensive Care (MIMIC)-IV and MIMIC-III database. Consensus clustering based on hierarchical clustering was employed for subphenotype derivation. Nine supervised classifiers were employed to construct the subphenotype classifier, including random forest (RF), extreme gradient boosting (XGBoost), support vector machine (SVM), partial least squares (PLS), neural network (NN), naïve Bayes (NB), linear discriminant analysis (LDA), least absolute shrinkage and selection operator (LASSO), and adaptive boosting (AdaBoost.M1). Subphenotype-specific propensity score-derived stabilized inverse probability of treatment weights was used to weight comparisons of intensive care unit and hospital lengths of stay and discharge dispositions across subphenotypes.
resultsAmong 1535 septic patients with NOAF, three distinct subphenotypes emerged: Phenotype A was the mildest subgroup; Phenotype B exhibited pronounced metabolic acidosis, highest anion gap, severe renal impairment, and elevated severity scores; Phenotype C showed intermediate laboratory values and score profiles with notable hyperchloremia and inflammatory markers. A parsimonious model established by SVM showed the best effectiveness. HR-control therapy was associated with subphenotype-specific reductions in hospital and ICU lengths of stay and more favorable discharge dispositions in Phenotype A, while more favorable survival outcomes were observed across all three subphenotypes in IPTW-weighted analyses.
conclusionCluster analysis revealed three clinically relevant subphenotypes among septic patients with NOAF, each demonstrating distinct clinical outcomes and heterogeneous responses to heart rate control therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.